VIAP Financials 07/16/2014 01:55:19 VIA Pharmaceu
Post# of 4
Posted On: 07/16/2014 2:55:16 AM
VIAP Financials 07/16/2014 01:55:19
VIA Pharmaceuticals, Inc.
Period Ending Dec 31, 2010
Total Revenue -
Cost of Revenue -
Gross Profit -
Operating Expenses
Research and Development 1,817
Sales, General and Admin. 4,097
Non-Recurring Items 107
Other -
Operating Income (6,021)
Income From Continuing Operations
Add'l Income/Expense Items (18)
Earnings Before Interest and Tax (6,039)
Interest Expense 3,562
Earnings Before Tax (9,601)
Income Tax -
Minority Interest -
Equity Earnings Unconsolidated Subsidiary -
Net Income Cont. Operations (9,601)
Non Recurring Events
Discontinued Operations -
Extraordinary Items -
Effect of Accounting Changes -
Other Items -
Net Income (9,601)
Preferred Stock and Other Adjustments -
Net Income Applicable to Common Shareholders (9,601)
VIA Pharmaceuticals, Inc.
Period Ending Dec 31, 2010
Total Revenue -
Cost of Revenue -
Gross Profit -
Operating Expenses
Research and Development 1,817
Sales, General and Admin. 4,097
Non-Recurring Items 107
Other -
Operating Income (6,021)
Income From Continuing Operations
Add'l Income/Expense Items (18)
Earnings Before Interest and Tax (6,039)
Interest Expense 3,562
Earnings Before Tax (9,601)
Income Tax -
Minority Interest -
Equity Earnings Unconsolidated Subsidiary -
Net Income Cont. Operations (9,601)
Non Recurring Events
Discontinued Operations -
Extraordinary Items -
Effect of Accounting Changes -
Other Items -
Net Income (9,601)
Preferred Stock and Other Adjustments -
Net Income Applicable to Common Shareholders (9,601)
(0)
(0)Via Pharmaceuticals Inc. (VIAP) Stock Research Links
Scroll down for more posts ▼